Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays

Journal of Immunological Methods

Volumn 362, Issue 1-2, 2010, Pages 199-203

  Williams, Alistair J K ^a   Curnock, Rachel ^a   Reed, Charles R ^a   Easton, Peter ^a   Rokni, Saba ^a   Bingley, Polly J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Bovine serum albumin; Insulin autoantibody assays; Non specific binding

Indexed keywords

ALBUMIN ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; INSULIN ANTIBODY; INSULIN I 125; OVALBUMIN;

ADOLESCENT; ADULT; ANTIGEN BINDING; ARTICLE; BINDING ASSAY; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; IMMUNOASSAY; INFANT; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PURIFICATION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; CATTLE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; INFANT; INSULIN; MALE; RADIOIMMUNOASSAY; SERUM ALBUMIN, BOVINE;

BOVINAE;

EID: 77958496555     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.09.009     Document Type: Article

References (10)

1. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., Gale E.A. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997, 46:1701.
2. Bingley P.J., Williams A.J., Gale E.A. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999, 22:1796.
3. Hegewald M.J., Schoenfeld S.L., McCulloch D.K., Greenbaum C.J., Klaff L.J., Palmer J.P. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes. J. Immunol. Methods 1992, 154:61.
4. Naserke H.E., Dozio N., Ziegler A.G., Bonifacio E. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 1998, 41:681.
5. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337.
6. Schlosser, M., Mueller, P.W., Torn, C., Bonifacio, E., Bingley, P.J. and Participating Laboratories, (in press). Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia. http://doi:10.1007/s00125-010-1915-5.
7. Vardi P., Dib S.A., Tuttleman M., Connelly J.E., Grinbergs M., Radizabeh A., Riley W.J., Maclaren N.K., Eisenbarth G.S., Soeldner J.S. Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987, 36:1286.
8. Williams A.J., Bingley P.J., Bonifacio E., Palmer J.P., Gale E.A. A novel micro-assay for insulin autoantibodies. J. Autoimmun. 1997, 10:473.
9. Williams A.J., Norcross A.J., Chandler K.A., Bingley P.J. Non-specific binding to protein A sepharose and protein G sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine. J. Immunol. Methods 2006, 314:170.
10. Yu L., Robles D.T., Abiru N., Kaur P., Rewers M., Kelemen K., Eisenbarth G.S. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl Acad. Sci. USA 2000, 97:1701.